3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Recruiting
2
Sponsor Class
OTHER
170
INDUSTRY
49
NIH
13
OTHER_GOV
4
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Ovarian Neoplasms
117
Uterine Cervical Neoplasms
65
Carcinoma, Ovarian Epithelial
64
Fallopian Tube Neoplasms
62
Endometrial Neoplasms
38
Brenner Tumor
22
Sarcoma
18
Testicular Neoplasms
15
Vulvar Neoplasms
12
Squamous Intraepithelial Lesions
10
Sarcoma, Endometrial Stromal
10
Endometrial Adenocarcinoma
10
Breast Neoplasms
10
Ovarian Germ Cell Cancer
9
HIV Infections
9
Teratoma
7
Sarcoma, Synovial
7
Precancerous Conditions
7
Osteosarcoma
7
Neurofibrosarcoma
7
Neuroblastoma
7
Melanoma
7
Liposarcoma
7
Leiomyosarcoma
7
Histiocytoma, Malignant Fibrous
7
Hemangiosarcoma
7
Fibrosarcoma
7
Carcinoma, Non-Small-Cell Lung
7
Uterine Cervical Dysplasia
6
Stomach Neoplasms
6
Interventions
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Peritoneal Neoplasms
×
Gynecologic
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled
NCT04111978
2025-09-29
MATAO
Swiss GO Trial Group
Phase 3
Recruiting
540 enrolled